Prof. Dr. Rami Ahmad | Cancer Therapy | Best Researcher Award

Senior Researcher | Czech Education and Scientific Network | Czech Republic

Prof. Dr. Rami Ahmad El-Nabulsi is a distinguished theoretical physicist and applied mathematician whose research bridges nonlinear quantum dynamics, fractal mechanics, plasma and solid-state physics, and advanced mathematical modeling. Holding a PhD in Particle and Mathematical Physics from AMU, along with postgraduate diplomas in Plasma Physics and degrees in Physics at both master’s and bachelor’s levels, he has built a prolific career combining theoretical rigor with computational innovation. He is currently affiliated with the Center of Excellence in Quantum Technology, Faculty of Engineering, and the Quantum-Atom Optics Laboratory at Chiang Mai University, Thailand, as well as with the University of South Bohemia and the Department of Optical Networks CESNET in the Czech Republic. Prof. El-Nabulsi’s research interests encompass geometrical and quantum dynamics, nonlinear systems, chaos and bifurcations, general relativity, quantum field theory, and the application of fractional and fractal calculus to complex systems in engineering, astrophysics, and materials science. His expertise extends to advanced computational modeling, partial differential equations, stochastic systems, and numerical simulations. He has received multiple international honors, including the Outstanding Scientist Research Award and the Lifetime Achievement Award. A reviewer for more than 250 scientific journals and an editorial board member in over 40 peer-reviewed publications, he has authored more than 390 research articles in high-impact international journals and is frequently invited as an honorary speaker at global conferences. Prof. El-Nabulsi’s academic dedication, multidisciplinary approach, and sustained research excellence continue to shape theoretical and applied physics worldwide. His scholarly impact is reflected in 4,873 citations, 277 documents, and an h-index of 35, underscoring his influential role in advancing modern fractal physics and nonlinear dynamical systems research.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. El-Nabulsi, R. A., & Anukool, W. (2025). Chaotic and fractal maps in higher-order derivative dynamical systems. Frontiers in Physics, 12, 1529644. Cited by: 8

2. El-Nabulsi, R. A., & Anukool, W. (2025). Qualitative financial modelling in fractal dimensions. Financial Innovation, 11, 42. Cited by: 6

3. El-Nabulsi, R. A. (2025). A fractional model to study soliton in presence of charged space debris at low-Earth orbital plasma region. IEEE Transactions on Plasma Science, 52(9), 4671–4693. Cited by: 4

4. El-Nabulsi, R. A., & Golmankhaneh, A. K. (2025). Propagation of waves in fractal spaces. Waves in Random and Complex Media. Cited by: 4

5. El-Nabulsi, R. A., & Anukool, W. (2025). Vlasov equation, waves and dispersion relations in fractal dimensions: Landau damping and the toroidal ion temperature gradient instability problem. Waves in Random and Complex Media. Cited by: 14

6. El-Nabulsi, R. A. (2024). Transition from circular to spiral waves and from Mexican hat to upside-down Mexican hat-solutions: The cases of local and nonlocal λ–ω reaction–diffusion–convection fractal systems with variable coefficients. Chaos, Solitons & Fractals, 189, 115737. Cited by: 3

7. El-Nabulsi, R. A. (2024). Modelling nematic liquid crystal in fractal dimensions. Medicine in Novel Technology and Devices, 24, 100334. Cited by: 7

Cancer Research and Advocacy

Introduction: Cancer Research and Advocacy stand as pillars in the global effort to combat cancer, addressing both the scientific exploration of this complex disease and the vital support and awareness needed for patients and their families. Together, they strive to improve prevention, early detection, and treatment while championing the rights and well-being of those affected by cancer.

Advancements in Cancer Research: Dive into the latest breakthroughs in cancer research, including novel treatment modalities, understanding cancer genetics, and exploring emerging technologies like artificial intelligence in cancer diagnosis and prognosis.

Patient-Centric Care: Explore the advocacy efforts focused on ensuring patients receive the best possible care, including initiatives to enhance access to treatment, improve patient outcomes, and promote a patient-centered healthcare system.

Early Detection and Screening: Investigate the critical role of early detection in cancer survival rates and advocacy campaigns aimed at raising awareness about the importance of regular screenings and diagnostic tools.

Cancer Prevention and Education: Examine initiatives and programs that educate the public about risk factors, lifestyle choices, and preventive measures to reduce the incidence of cancer.

Support and Survivorship: Learn about the various support networks, survivorship programs, and advocacy efforts dedicated to enhancing the quality of life for cancer survivors and their families, addressing emotional, psychological, and practical needs.

Policy and Legislation: Delve into the advocacy work related to cancer-related policies, funding for research, and healthcare legislation, as well as the impact of these policies on cancer patients and research institutions.

Clinical Trials and Access: Explore how advocacy groups work to improve access to clinical trials, promote transparency in research, and advocate for equitable distribution of innovative cancer therapies.

Global Initiatives: Discover international collaborations and organizations dedicated to advancing cancer research and advocacy efforts on a global scale, addressing disparities in cancer care and research across different regions.

Public Awareness Campaigns: Investigate the effectiveness of public awareness campaigns in raising funds, fostering empathy, and reducing stigma associated with cancer, and how these campaigns drive support for research and patient care.

Survivor and Patient Advocacy: Highlight the role of individuals who have experienced cancer firsthand in advocating for policy changes, increased research funding, and improved patient care, and their impact on the cancer community.